Australian government says vaccine risk too high for people under 30
The Australian government says the risk of myocarditis from a COVID booster might be greater than COVID itself β€” so it won’t allow people under 30 to get a fourth vaccine.

Mike Campbell

November 14, 2022

The Australian government says the risk of myocarditis from a COVID booster might be greater than COVID itself β€” so it won’t allow people under 30 to get a fourth vaccine.

Australian government says vaccine risk too high for people under 30
Australian government says vaccine risk too high for people under 30.

“In males aged 16-40 years, it is uncertain whether the risk following COVID-19 remains higher than the risk following vaccination,” the government said.

The government considers myocarditis and pericarditis following COVID vaccination severe enough to warrant a 13-page guideline. The guideline is updated regularly. 

“The majority of cases of myocarditis reported after COVID-19 vaccines have occurred in males under 40, and the majority have occurred within 1-5 days (median 2 days) following the second dose of an mRNA vaccine. Myo/pericarditis is more common after the second dose of Moderna compared with second doses of Pfizer and AstraZeneca.”

The guidance further states that there are no studies on the long-term dangers of myocarditis following COVID vaccination. The government says most cases result in hospitalization and some in death.

Last week, Pfizer and Moderna launched clinical trials to study the long-term effects of myocarditis following vaccination with its mRNA vaccines. The launch comes roughly 18 months after the products went to market with a promise of being “safe and effective.”

NBC News reports that the Food and Drug Administration (FDA) required the drugmakers to conduct the study. It was needed as part of the emergency-use approval process that allowed the drugs to go to market before clinical trials were completed. 

In July, Ontario Chief Medical Officer Kieran Moore announced that a fourth vaccine is now available for everyone over 18. However, he said not everyone should get another vaccine due to the risk of myocarditis. 

Moore also suggested the “vaccine” is therapeutic.

β€œThere’s always a risk to having any therapeutic versus a benefit. You want to make sure there’s a very strong benefit versus the risk. If you’re an 18-year-old healthy individual, the risk of getting hospitalized if you have no underlying medical illness is very, very low,” Moore said.

Share this story

Help Keep your News Free

Share this story

It's crucial we stay in touch

Big Tech wants to censor us, that’s why you need to stay in touch.

YOU MIGHT ALSO LIKE THESE...

Trending News

In an interview, Foreign Affairs Minister Melanie Joly said, β€œListen, when I hear these loaded words, I feel that it’s really hurting our democracy. Because fundamentally, foreign interference is a real thing.”

TCS Wire

June 18, 2024

Trending News

Trudeau announced he’s sending another $52.4 million to Ukraine but is holding off on sending CAF members.

TCS Wire

June 17, 2024

Trending News

According to Abacus polling data, 26% of Canadians now list immigration as one of their top three issues.

TCS Wire

June 17, 2024

Trending News

With political tensions rising and an economy in decline, Canadians have formed strong opinions of several countries, many of them negative.

TCS Wire

June 13, 2024

Trending News

Trudeau gets internationally mocked again, this time by Sky News.

TCS Wire

June 12, 2024

Trending News

The Liberals have been forced to admit that the number of wildfires across the country is well below the 10-year average.

TCS Wire

June 12, 2024

We use cookies to personalise content and ads, to provide social media features and to analyse our traffic. We also share information about your use of our site with our social media, advertising and analytics partners who may combine it with other information that you’ve provided to them or that they’ve collected from your use of their services. You consent to our cookies if you continue to use our website.